Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over
SARCOLD
Evaluation of the Impact of Locoregional Treatment of Soft Tissue Sarcoma on the Functional Status of Patients Aged 70 Years and Over
1 other identifier
interventional
25
1 country
1
Brief Summary
In order to describe functional impact of surgery in elderly patients treated for lower-limb soft-tissue sarcoma, the investigators set up this project which aims to identify prognostic factors among geriatric and functional assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 20, 2017
CompletedFirst Posted
Study publicly available on registry
March 10, 2017
CompletedStudy Start
First participant enrolled
November 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedJanuary 30, 2026
January 1, 2026
5.1 years
February 20, 2017
January 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Physical functioning assessment
Quality of life questionnaire QLQ-C30
Change from baseline until 36 months after surgery
Secondary Outcomes (7)
Functional status assessment (TESS)
Change from baseline until 36 months after surgery
Functional status assessment (MST)
Change from baseline until 36 months after surgery
Quality of life assessment QLQ-C30
Change from baseline until 36 months after surgery
Quality of life assessment QLQ-EDL-14
Change from baseline until 36 months after surgery
Geriatric parameters assessment - G8
baseline
- +2 more secondary outcomes
Study Arms (1)
Prospective cohort
EXPERIMENTALGeriatric assessment
Interventions
Eligibility Criteria
You may qualify if:
- Aged more than 70 years,
- Soft tissue sarcoma histologically proven,
- Sarcoma of the soft tissues of the lower limbs,
- Operable disease (first-line treatment or neo-adjuvant therapy),
- ECOG, Performance Status ≤ 2,
- Decision of surgery validated in Multidisciplinary Consultation Meeting,
- Reports of the non-opposition documented in the patient file before any procedure specific to the study,
- Affiliation to system of Social Security (accordance with article L1121-11 of the Code of Public Health).
You may not qualify if:
- Metastatic disease from the onset or relapse
- Participation in another study involving a similar geriatric assessment.
- Geographic, familial, social, psychological or psychiatric factors that make the patient incapable of undergoing the study's follow-up and procedures.
- Persons deprived of liberty or placed under judicial protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Bergoniélead
- Ministry of Health, Francecollaborator
Study Sites (1)
Institut Bergonié
Bordeaux, 33076, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2017
First Posted
March 10, 2017
Study Start
November 30, 2017
Primary Completion
January 15, 2023
Study Completion
March 1, 2026
Last Updated
January 30, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share